Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-03-29

Clinical Trial Update: Repository Study of Autosomal Dominant Polycystic Kidney Disease

View source ↗

Summary

The repository study for autosomal dominant polycystic kidney disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Rogosin Institute | Conditions: Autosomal Dominant Polycystic Kidney Disease | Status: WITHDRAWN